報價延遲最少15分鐘:2026/03/30 11:24 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
116.54 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.47/--
|
|
企業價值
4.29B
|
| 資產負債 |
|
每股賬面淨值
36.83
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
980.60M
|
|
每股收益
24.90
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States. |
